Overview
ABO typing detects A and B antigens on red cells (forward type) and anti-A/anti-B isoagglutinins in plasma/serum (reverse type) to assign group A, B, AB, or O.
Clinical Importance
Establish patient and donor ABO group for transfusion compatibility
Investigate ABO discrepancies before product issue
Specimen Requirements
- Specimen: whole blood (EDTA preferred for most typing, screens, and crossmatches)
- Tube: lavender/pink-top K₂EDTA (follow institutional blood bank tube color policy)
- Identity: two unique patient identifiers; many sites require a witnessed/type-and-screen collection process
- Handling: mix gently; do not use grossly hemolyzed specimens for serologic interpretation without investigation
- Timing: specimen age limits for pretransfusion testing are SOP-/standards-defined (commonly ≤3 days for patients who may have been transfused or pregnant recently; verify local AABB-aligned policy)
Analytical Method
Forward typing mixes patient red cells with anti-A, anti-B (± anti-A,B). Reverse typing mixes patient plasma/serum with A1 and B reagent cells. Reactions are read by tube, gel, or solid-phase methods. Forward and reverse must agree before reporting.
Instruments Used
Automated analyzers
- Ortho Vision / Ortho Clinical Diagnostics automated immunohematology systems
- Bio-Rad IH-1000 / IH-500 and related gel/column systems
- Grifols Erytra / Wadiana automated blood typing systems
- Immucor NEO / Echo luminescent immunohematology systems
- Manual tube testing with centrifugation and macroscopic reading
- Column agglutination (gel/bead) card systems
- Solid-phase red cell adherence platforms
Manual methods
- Manual tube testing with immediate-spin and AHG phases as applicable
Reference Values
Immunohematology interpretations follow institutional SOPs aligned with AABB Standards, ISBT terminology, and applicable CLSI / BSH guidance. Reagent lots, method (tube, gel, solid-phase), and patient history critically affect results; always verify against the performing laboratory’s current procedure and applicable standards edition.
Expected: concordant forward and reverse typing yielding group A, B, AB, or O. Discrepancies are not reported as a final group until resolved.
Neonates may lack reverse-type isoagglutinins; interpret per neonatal SOP.
Interpretation
Critical blood bank findings (e.g., ABO discrepancy blocking issue, positive crossmatch when blood is needed urgently, acute hemolytic transfusion reaction workup) follow institutional urgent-notification pathways. Confirm the local call list.
Critical values
- Unresolved ABO discrepancy when transfusion is requested; do not issue ABO-specific RBCs until policy allows (often group O until resolved)
Common Causes of Increased Results
- Strong agglutination with anti-A and/or anti-B defines antigen presence; reverse reactions define expected isoagglutinins
Common Causes of Decreased Results
- Missing or weak reverse reactions (infants, elderly, immunosuppression) or weak subgroups cause discrepancies requiring investigation
Clinical Significance
- Pretransfusion type and screen / type and crossmatch
- Donor unit confirmation
- Transplant and prenatal ABO determination
Factors Affecting Results
Pre-analytical
- Patient misidentification or unlabeled/mislabeled specimens
- Wrong tube type or clotted EDTA specimen when plasma is required
- Specimen older than institutional pretransfusion dating limits
- IV fluid contamination or draw above an infusion
- Sample mix-up is the most dangerous ABO error source
Analytical
- Subgroups of A, acquired B, rouleaux, cold autoantibodies
- Recent transfusion or hematopoietic transplant causing mixed-field reactions
Post-analytical
- Transcription/LIS mapping errors of ABO/Rh or antibody results
- Issuing products before resolving ABO discrepancies or positive screens per policy
- Incomplete documentation of special requirements (antigen-negative, irradiated, etc.)
Advantages and Limitations
Advantages
- Foundational compatibility test
- Forward + reverse provides internal cross-check
Limitations
- Discrepancies require skilled workup
- Automation still needs human review of flags
Clinical Pearls
If forward and reverse disagree, you do not have a blood type yet; you have a problem to solve.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- Cohn CS, Delaney M, Johnson ST, Katz LM, eds. Technical Manual. 21st ed. AABB; 2023.
- Fung MK, Eder AF, Spitalnik SL, Westhoff CM, eds. Technical Manual. 20th ed. AABB; 2020.
- Harmening DM. Modern Blood Banking & Transfusion Practices. 7th ed. F.A. Davis; 2019.
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
- Bain BJ, Bates I, Laffan MA, eds. Dacie and Lewis Practical Haematology (verify current edition). Blood transfusion chapters.
CLSI and Professional Guidelines
- AABB. Standards for Blood Banks and Transfusion Services (verify current edition and institutional adoption).
- U.S. Food and Drug Administration. Code of Federal Regulations Title 21 . Blood and Blood Components (verify current institutional adoption).
- World Health Organization. Blood safety and availability / transfusion guidance (verify current WHO publication and institutional adoption).
- Clinical and Laboratory Standards Institute. Related immunohematology and specimen identity standards (verify current documents and institutional adoption).
- International Society of Blood Transfusion (ISBT). Blood group terminology and transfusion guidance (verify current ISBT publications).
- British Society for Haematology (BSH). Guidelines for blood grouping, antibody testing, and transfusion practice (verify current BSH guideline editions).
- Clinical and Laboratory Standards Institute. Immunohematology, specimen identification, and related transfusion laboratory documents (verify current CLSI editions).
WHO Publications
- World Health Organization. Blood safety, availability, and clinical transfusion guidance (verify current WHO publication).
Frequently Asked Questions
Common questions about using this ABO Blood Grouping laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the ABO Blood Grouping laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of ABO Blood Grouping. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find ABO Blood Grouping specimen requirements?
See the Specimen Requirements section on this page for specimen information related to ABO Blood Grouping. Confirm collection details against your laboratory protocol.
Where are ABO Blood Grouping reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret ABO Blood Grouping results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for ABO Blood Grouping?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from ABO Blood Grouping?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading ABO Blood Grouping?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Blood Bank / Transfusion Medicine topic.
What are the clinical pearls for ABO Blood Grouping?
See the Clinical Pearls section for concise laboratory practice notes associated with ABO Blood Grouping. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.